Standard
Methotrexate for inflammatory bowel disease : time for reconsideration. / Nielsen, Ole Haagen; Ainsworth, Mark Andrew; Steenholdt, Casper.
In:
Expert Review of Gastroenterology and Hepatology, Vol. 13, No. 5, 2019, p. 407-409.
Research output: Contribution to journal › Editorial › Research › peer-review
Harvard
Nielsen, OH, Ainsworth, MA
& Steenholdt, C 2019, '
Methotrexate for inflammatory bowel disease: time for reconsideration',
Expert Review of Gastroenterology and Hepatology, vol. 13, no. 5, pp. 407-409.
https://doi.org/10.1080/17474124.2019.1596797
APA
Nielsen, O. H., Ainsworth, M. A.
, & Steenholdt, C. (2019).
Methotrexate for inflammatory bowel disease: time for reconsideration.
Expert Review of Gastroenterology and Hepatology,
13(5), 407-409.
https://doi.org/10.1080/17474124.2019.1596797
Vancouver
Nielsen OH, Ainsworth MA
, Steenholdt C.
Methotrexate for inflammatory bowel disease: time for reconsideration.
Expert Review of Gastroenterology and Hepatology. 2019;13(5):407-409.
https://doi.org/10.1080/17474124.2019.1596797
Author
Nielsen, Ole Haagen ; Ainsworth, Mark Andrew ; Steenholdt, Casper. / Methotrexate for inflammatory bowel disease : time for reconsideration. In: Expert Review of Gastroenterology and Hepatology. 2019 ; Vol. 13, No. 5. pp. 407-409.
Bibtex
@article{d3900835c35c4d0ba857ac8b30af5328,
title = "Methotrexate for inflammatory bowel disease: time for reconsideration",
keywords = "biologics, Crohn{\textquoteright}s disease, inflammatory bowel disease, methotrexate, therapy, ulcerative colitis",
author = "Nielsen, {Ole Haagen} and Ainsworth, {Mark Andrew} and Casper Steenholdt",
year = "2019",
doi = "10.1080/17474124.2019.1596797",
language = "English",
volume = "13",
pages = "407--409",
journal = "Expert Review of Gastroenterology & Hepatology",
issn = "1747-4124",
publisher = "Taylor & Francis",
number = "5",
}
RIS
TY - JOUR
T1 - Methotrexate for inflammatory bowel disease
T2 - time for reconsideration
AU - Nielsen, Ole Haagen
AU - Ainsworth, Mark Andrew
AU - Steenholdt, Casper
PY - 2019
Y1 - 2019
KW - biologics
KW - Crohn’s disease
KW - inflammatory bowel disease
KW - methotrexate
KW - therapy
KW - ulcerative colitis
U2 - 10.1080/17474124.2019.1596797
DO - 10.1080/17474124.2019.1596797
M3 - Editorial
C2 - 30895827
AN - SCOPUS:85063127511
VL - 13
SP - 407
EP - 409
JO - Expert Review of Gastroenterology & Hepatology
JF - Expert Review of Gastroenterology & Hepatology
SN - 1747-4124
IS - 5
ER -
